Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer.

Autor: Mercer-Smith AR; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Jiang W; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Bago JR; Department of Hemato-Oncology, University of Ostrava, Ostrava, Czech Republic., Valdivia A; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Thang M; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Woodell AS; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Montgomery SA; Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Sheets KT; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Anders CK; Department of Medicine, Duke University, Durham, North Carolina., Hingtgen SD; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. hingtgen@email.unc.edu.; Department of Neurosurgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Nov; Vol. 20 (11), pp. 2291-2301. Date of Electronic Publication: 2021 Aug 25.

Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.

Autor: Sheets KT; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Ewend MG; Department of Neurosurgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Mohiti-Asli M; Department of Biomedical Engineering, North Carolina State University, Raleigh, NC, USA., Tuin SA; Department of Biomedical Engineering, North Carolina State University, Raleigh, NC, USA., Loboa EG; College of Engineering, University of Missouri-Columbia, Columbia, MO 65211, USA., Aboody KS; Department of Developmental and Stem Cell Biology, Division of Neurosurgery, City of Hope, Duarte, CA 91010, USA., Hingtgen SD; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: hingtgen@email.unc.edu.

Publikováno v: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2020 Apr 08; Vol. 28 (4), pp. 1056-1067. Date of Electronic Publication: 2020 Feb 13.

Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.

Autor: Graham-Gurysh E; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Moore KM; Joint Department of Biomedical Engineering , University of North Carolina at Chapel Hill and North Carolina State University , Raleigh , North Carolina 27695 , United States., Satterlee AB; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Sheets KT; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Lin FC; Department of Biostatistics and North Carolina Translational and Clinical Sciences Institute , University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Miller CR; Division of Neuropathology, Department of Pathology and Laboratory Medicine, Departments of Neurology and Pharmacology, Lineberger Comprehensive Cancer Center, and Neuroscience Center, School of Medicine , University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Hingtgen SD; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics , Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States.

Publikováno v: Molecular pharmaceutics [Mol Pharm] 2018 Mar 05; Vol. 15 (3), pp. 1309-1318. Date of Electronic Publication: 2018 Feb 02.

Neural stem cell therapy for cancer.

Autor: Bagó JR; Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Sheets KT; Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Hingtgen SD; Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Biomedical Research Imaging Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: hingtgen@email.unc.edu.

Publikováno v: Methods (San Diego, Calif.) [Methods] 2016 Apr 15; Vol. 99, pp. 37-43. Date of Electronic Publication: 2015 Aug 24.